- Home
- GIGM vs BFRG Comparison
GIGM vs BFRG Comparison
Compare GIGM & BFRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GIGM | BFRG |
|---|---|---|
| Founded | 1998 | 2017 |
| Country | Taiwan | United States |
| Employees | N/A | 17 |
| Industry | Computer Software: Programming Data Processing | Retail: Computer Software & Peripheral Equipment |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.9M | 12.8M |
| IPO Year | 2002 | N/A |
Fundamental Metrics
Financial Performance| Metric | GIGM | BFRG |
|---|---|---|
| Price | $1.33 | $0.61 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 5.1K | ★ 121.1K |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.29 | $0.43 |
| 52 Week High | $1.89 | $2.04 |
Technical Indicators
Market Signals| Indicator | GIGM | BFRG |
|---|---|---|
| Relative Strength Index (RSI) | 39.80 | 37.77 |
| Support Level | $1.30 | $0.59 |
| Resistance Level | $1.51 | $0.69 |
| Average True Range (ATR) | 0.06 | 0.05 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 8.70 | 17.35 |
Price Performance
Historical ComparisonAbout GIGM GigaMedia Limited
GigaMedia Ltd is a diversified provider of digital entertainment services. The only segment and principal business of the company is digital entertainment service business, that operates a portfolio of digital entertainment products, targeting digital entertainment service users across Asia. The company operates digital entertainment business in Taiwan, Hong Kong and Macau through FunTown. The company generates majority revenue from Taiwan.
About BFRG Bullfrog AI Holdings Inc.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. The Company is focused specifically on advance artificial intelligence and machine learning (AI/ML)- driven analysis of complex datasets in medicine and healthcare. The Company's objective is to use its AI/ML platform to provide a precision-medicine approach to drug-asset enablement through external partnerships and selective internal development.